Pfizer Warns 2024 Revenue Could Fall, Weighed Down by Soft Demand for Covid Products
Wall Street Journal
Pfizer said revenue could fall next year, weighed down by a continued slowdown in demand for the pharmaceutical company’s Covid-19 vaccine and related products.